Client News

Allecra Therapeutics Announces Late-breaker Presentation of Phase 3 ALLIUM Trial with Cefepime-Enmetazobactam in cUTIs at IDWeek 2020

Verona Pharma plc: Verona Pharma to Announce Interim Results for the Three and Nine Months Ended September 30, 2020 and Provide Corporate Update

CENTOGENE GmbH: CENTOGENE gibt Führungswechsel bekannt

Atriva Therapeutics GmbH: Germany: EIB backs Atriva Therapeutics with €24 million for the development of a potential COVID-19 treatment

HepaRegeniX GmbH hires industry veteran Dr David Shapiro as Senior Medical Advisor

Adocia Announces Third Quarter 2020 Financial Results

CEVEC and Rznomics sign license agreement for the use of CAP® Technology in manufacturing of adenoviral vectors

CENTOGENE GmbH: CENTOGENE Receives FDA Emergency Use Authorization for SARS-CoV-2 RT-PCR Assay for Individuals Without Symptoms or Other Reasons to Suspect COVID-19

Media Advisory: BIO-Europe® Digital | October 26–29, 2020 | European Standard Time

Topas Therapeutics Raises €22 Million (~USD 26 Million) in Series B Financing